Elizabethtown, PA, United States of America

Brian M Barth

USPTO Granted Patents = 2 

Average Co-Inventor Count = 9.3

ph-index = 2

Forward Citations = 16(Granted Patents)


Location History:

  • Hummelstown, PA (US) (2014)
  • Elizabethtown, PA (US) (2015)

Company Filing History:


Years Active: 2014-2015

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Brian M Barth

Introduction

Brian M Barth is an accomplished inventor based in Elizabethtown, PA (US). He holds 2 patents that focus on advanced biomedical applications. His work primarily revolves around the development of innovative nanoparticle technologies for targeted drug delivery and imaging.

Latest Patents

One of his latest patents is titled "Bioconjugation of calcium phosphosilicate nanoparticles for selective targeting of cells in vivo." This invention involves non-aggregating resorbable calcium phosphosilicate nanoparticles (CPNPs) that are bioconjugated to targeting molecules specific for particular cells. The CPNPs are stable at normal physiological pH, allowing for the compartmentalization of chemotherapy and imaging agents within the nanoparticles. This method ensures that the agents are protected from environmental interactions until they are taken up by the target cells, where they are released at intracellular pH. This innovative approach limits systemic exposure while delivering a higher concentration of agents directly to the cells.

Another significant patent by Barth is "In vivo photodynamic therapy of cancer via a near infrared agent encapsulated in calcium phosphate nanoparticles." This invention describes the use of nano-encapsulated photosensitizers for tumor treatment and imaging. By encapsulating the photosensitizers in calcium phosphate nanoparticles, the half-life and absorption of the agents into target tissues are significantly enhanced. This results in improved photostability and photoefficiency, making it a highly effective solution for photodynamic therapy and tumor detection.

Career Highlights

Brian M Barth is associated with the Penn State Research Foundation, where he contributes to cutting-edge research in nanotechnology and its applications in medicine. His work has the potential to revolutionize cancer treatment and improve patient outcomes through targeted therapies.

Collaborations

Throughout his career, Barth has collaborated with notable colleagues, including James H Adair and Mark Kester. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to significant advancements in their field.

Conclusion

Brian M Barth's contributions to the field of biomedical engineering through his innovative patents demonstrate his commitment to advancing medical technology. His work in nanoparticle development is paving the way for more effective cancer treatments and improved imaging techniques.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…